Drug recall · June 26, 2019
Allergy Relief D recall
Why: Testing of Fexofenadine HCl and Pseudoephedrine Failed Impurities/Degradation Specifications: elevated substance results that were reported above or near the specification limit
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Allergy Relief D, Fexofenadine HCl 60 mg/ Pseudoephedrine HCl 120 mg, Extended Release Tablets, USP, 30-count box, Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895. Made in India. UPC 0 50428 39131 0
- Lots / codes
Lot: GKT0484B, EXP 04/2020
- Quantity
- 9528 30 count units
- Company
- Sun Pharmaceutical Industries, Inc., Cranbury, NJ
- Distribution
- Nationwide in the USA
- Initiated
- June 5, 2019 · Voluntary: Firm initiated
- Classified
- June 14, 2019
- Reported
- June 26, 2019
- Ended
- January 8, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Fexofenadine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.